Details of the Drug Reposition

General Information of This Drug (ID: DMAY0CG)

Drug Name
INN-108   DMAY0CG
Synonyms
5-(4-Carboxymethyl-Phenylazo)-2-Hydroxy-Benzoic Acid; UNII-QIU74LKJ78; QIU74LKJ78; Nobex-AA-004; SCHEMBL1636172; 5-((E)-(4-(Carboxymethyl)phenyl)azo)-2-hydroxy-benzoic acid; Benzeneacetic acid, 4-(2-(3-carboxy-4-hydroxyphenyl)diazenyl)-; 402934-69-4
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Ulcerative colitis DIS8K27O DD71 Phase 1 [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Inflammatory bowel disease DISGN23E DD72 Discontinued in Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017232)